Medicare confirms payment for prostate cancer drug
Thursday, June 30, 2011 - 17:00
in Health & Medicine
(AP) -- Medicare officials confirmed Thursday that the program will cover the $93,000 price tag for prostate cancer drug Provenge, an innovative therapy that typically gives men suffering from an incurable stage of the disease an extra four months to live.